Quest Diagnostics wins New York approval for cancer MRD test

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. ACN
4. IONS
5. AZN
6. ROIV
7. AAPL
8. NVDA
9. USO
10. ORCL

Go back to Quest Diagnostics wins New York approval for cancer MRD test
Quest Diagnostics (NYSE: DGX) Delayed: 236.20 -0.94 (0.4%)
Previous Close $237.14    52 Week High $86.85 
Open $233.61    52 Week Low $59.66 
Day High $236.29    P/E 44.48 
Day Low $231.52    EPS $5.31 
Volume 231,206